Document Detail


Up for Mischief? IL-17/Th17 in the tumour microenvironment.
MedLine Citation:
PMID:  20729908     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The role of interleukin (IL)-17 and the IL-17-producing T helper (Th)17 cells in cancer has recently become the focus of extensive investigation. An expanding body of literature implicates Th17 cells and their hallmark cytokine in both pro- and anti-tumourigenic processes. In this review we describe their biological activities and outline the reciprocal interactions between Th17 cells and other cells of the immune system. We also discuss the evidence regarding their dual role in the tumour microenvironment. An understanding of the processes that regulate the pro- or anti-tumour activities of Th17 cell and IL-17 will allow the development of more effective means for cancer immunotherapy.
Authors:
E Maniati; R Soper; T Hagemann
Related Documents :
20080398 - Autophagy: an adaptable modifier of tumourigenesis.
9575338 - Activation of cytotoxic t cells by solid tumours?
3496098 - Limited effects of recombinant human and murine interleukin 1 and tumour necrosis facto...
12603608 - Tumour-induced polarization of tumour vaccine-draining lymph node t cells to a type 1 c...
11054088 - Contrasting effects of hsp72 expression on apoptosis in human umbilical vein endothelia...
21785048 - Radiologic aspects of immune-related tumor response criteria and patterns of immune-rel...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2010-08-23
Journal Detail:
Title:  Oncogene     Volume:  29     ISSN:  1476-5594     ISO Abbreviation:  Oncogene     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-21     Completed Date:  2010-11-09     Revised Date:  2010-12-03    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  England    
Other Details:
Languages:  eng     Pagination:  5653-62     Citation Subset:  IM    
Affiliation:
Centre for Cancer and Inflammation, Institute of Cancer, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Humans
Interleukin-17 / immunology*
Neoplasms / immunology*
T-Lymphocyte Subsets / immunology*
T-Lymphocytes, Helper-Inducer / immunology*
Grant Support
ID/Acronym/Agency:
A11251//Cancer Research UK; G0601867(82107)//Medical Research Council; //Cancer Research UK; //Medical Research Council
Chemical
Reg. No./Substance:
0/Interleukin-17

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistan...
Next Document:  As we bring demethylating drugs to the clinic, we better know the DICE being cast.